Table 2. Comparison of 81 samples in 4 ranges of SSCA IHC level and divided into 3 groups: 27 squamous cell carcinomas (SCC) 27 verrucous carcinomas (VC) and 27 benign hyperplasia (BH).
| Diagnosis | 0 | 0-10 | 0-50 | 50-100 | Total |
|---|---|---|---|---|---|
| SCC | |||||
| Count | 10.00 | 10 | 6 | 1 | 27 |
| % within Diagnosis | 37.00% | 37.00% | 22.2% | 3.7% | 100,00% |
| % within SCCA IHC level | 90.9% | 31.3% | 24.00% | 7.7% | 33.3% |
| Adjusted Residual | 4.4 | -0.3 | -1.2 | -2.1 | |
| VC | |||||
| Count | 1.00 | 10 | 8 | 8 | 27 |
| % within Diagnosis | 3.7% | 37.00% | 29.6% | 29.6% | 100,00% |
| % within SCCA IHC level | 9.1% | 31.3% | 32.00% | 61.5% | 33.3% |
| Adjusted Residual | -1.8 | -0.3 | -0.2 | 2.4 | |
| BH | |||||
| Count | 0.00 | 12 | 11 | 4 | 27 |
| % within Diagnosis | 0.00% | 44.4% | 40.7% | 14.8% | 100,00% |
| % within SCCA IHC level | 0.00% | 37.5% | 44.00% | 30.8% | 33.3% |
| Adjusted Residual | -2.5 | 0.6 | 1.4 | -0.2 | |
| Total | |||||
| Count | 11.00 | 32 | 25 | 13 | 81 |
| % within Diagnosis | 13.6% | 39.5% | 30.9% | 16.00% | 100,00% |
| % within SCCA IHC level | 100.00% | 100.00% | 100.00% | 100,00% | 100,00% |